Gilead Sciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2013
Total Assets: $22.58B
Liabilities Breakdown FY2013
Total Liabilities: $11.21B
Asset Breakdown
Total Assets: $22.58B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.11B | 9.4% |
| Accounts Receivable | $2.18B | 9.7% |
| Inventory | $1.70B | 7.5% |
| Property, Plant & Equipment | $1.17B | 5.2% |
| Goodwill | $1.17B | 5.2% |
| Intangible Assets | $11.90B | 52.7% |
| Other Assets | $2.35B | 10.4% |
Liabilities Breakdown
Total Liabilities: $11.21B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.26B | 11.2% |
| Long-Term Debt | $3.94B | 35.1% |
| Other Liabilities | $6.01B | 53.7% |